An FDA advisory committee recommended that the agency approve Valeant’s brodalumab to treat moderate-to-severe plaque psoriasis.

Buried deep down in Novartis’ Q2 results out this morning was a previously unknown rejection by the FDA for a copycat version of Amgen’s blockbuster drug…

George Freeman has left the post of minister for life sciences as part of a reshuffle initiated by the new U.K. prime minister in the wake of the Brexit vote.

Another day, another unanimous FDA panel vote, this time recommending Novartis’ Enbrel (etanercept) biosimilar be approved across all of its U.S. licenses.

Amgen took one step closer to approval for its biosimilar of the world’s biggest-selling drug last night, but analysts don’t see it hitting the market this…

Juno Therapeutics was up by about 25% in after-hours trading on news that the FDA has already given it permission to resume the Phase II trial for its JCAR015…

Shire has been given a key U.S. approval for its new eye disease drug lifitegrast nearly a year after it was rejected by the FDA, and can now look to make good…

As the fallout continues from the shock announcement on Thursday that 3 patients died while being tested under Juno’s experimental CAR-T program, rival Kite…